The results of a pilot study presented today at the Annual European Congress of Rheumatology (EULAR 2019) suggest that electro stimulation of one of the nerves connecting the brain to the body (the vagus nerve), could provide a novel treatment approach for patients with rheumatoid arthritis.
“This is a really exciting development. For many patients suffering from rheumatoid arthritis, current treatments don’t work, or aren’t tolerated,” said Professor Thomas Dörner, Chairperson of the Scientific Programme Committee, EULAR. “These results open the door to a novel approach to treating not only rheumatoid arthritis, but other chronic inflammatory diseases. This is certainly an area for further study.”
The vagus nerve is the longest and the most complex of the 12 pairs of cranial nerves that originate from the brain. The name ‘vagus’ comes from the latin word for ‘wandering’. This is because the vagus nerve wanders from the brain into the organs of the neck, chest and abdomen.
Recent advances in neuroscience and immunology have mapped circuits in the brain that regulate immune responses. In one of the circuits, the ‘inflammatory reflex’, signals are transmitted in the vagus nerve that inhibit the production of cytokines including tumor necrosis factor (TNF), an inflammatory molecule that is a major therapeutic target in rheumatoid arthritis. It is thought that, by stimulating the activity of this inflammatory reflex, innate immune responses can be modulated without abolishing them or producing significant immunosuppression.
In this pilot study, a novel miniaturised neurostimulator called a MicroRegulator was implanted into 14 patients with rheumatoid arthritis who had failed on at least two biologics or targeted oral therapies with different mechanisms of action. Patients were randomised to three groups who were either placebo, stimulated once daily, or stimulated four times a day for 12 weeks. At the end of the study, the patients who received once-daily stimulation were shown to have a better response than those on four-times-daily stimulation with two thirds meeting the EULAR good or moderate response criteria and a mean change in DAS28-CRP of -1.24. The mean change in DAS28-CRP* in the placebo group was 0.16.1
Cytokines (a broad and loose category of small proteins that are important in cell signalling) were also measured in the study with the actively stimulated groups showing a decrease of more than 30% in levels of Interleukin (IL) 1?, IL-6, and TNF-?. Implantation and stimulation were generally well tolerated with no device or treatment-related SAEs and two surgery-related adverse events that resolved without clinically significant effects.
“Our pilot study suggests this novel MicroRegulator device is well tolerated and reduces signs and symptoms of rheumatoid arthritis,” said Mark Genovese, M.D., James W. Raitt Endowed Professor of Medicine, Stanford University, Stanford, California, USA. “These data support the study of this device in a larger placebo-controlled study as a novel treatment approach for rheumatoid arthritis and possibly other chronic inflammatory diseases.”
This study follows a proof-of-concept study which used reprogrammed epilepsy stimulators on the vagus nerve to demonstrate reduced systemic inflammation and improved disease activity in 17 patients with rheumatoid arthritis.
The study included 14 patients with active rheumatoid arthritis who had had an insufficient response to more than two biological disease modifying anti-rheumatic drugs (bDMARDs) or JAK inhibitors with more than two modes of action. All patients remained on stable background of methotrexate. The first three patients were implanted and stimulated after three weeks, following safety review board approval, the remaining 11 patients were implanted and randomised to one minute of stimulation once-daily, one minute of stimulation four times daily, or one minute of placebo stimulation.
Learn more: Vagus nerve stimulation study shows significant reduction in rheumatoid arthritis symptoms
The Latest on: Electro stimulation
[google_news title=”” keyword=”electro stimulation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Electro stimulation
- Hi Infidelity singer Dave Mikulskis rolls with the changes to fight Parkinson’son May 18, 2024 at 3:00 pm
Still, after he required a steadily increasing intake of medication, Mikulskis underwent deep brain stimulation surgery in 2021 at Northwestern ... connected to an electrical lead and electrodes in ...
- Q&A: When depression meds don't work, this may help you turn the corneron May 17, 2024 at 10:23 am
Some 30 to 40% of patients do not respond to medications for depression and obsessive-compulsive disorder (OCD), but half of them could be helped by a noninvasive in-office procedure.
- Next-generation quantum sensors detect human biomagnetismon May 16, 2024 at 8:30 am
Researchers are developing novel sensors that might be applied to next-generation magnetoencephalography systems ...
- NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Floridaon May 16, 2024 at 8:00 am
(“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, ...
- New Breakthrough Paves the Way for Vision Implants That Can Restore Sighton May 15, 2024 at 8:58 pm
A remarkably small implant, with electrodes the size of a single neuron that can also remain intact in the body over time – a unique combination that holds promise for future vision implants for the ...
- Some forms of augmented brain stimulation recommended for major depressionon May 15, 2024 at 9:45 am
According to a review published in Harvard Review of Psychiatry, certain combinations of medication or psychotherapy in conjunction with transcranial magnetic stimulation (TMS) or transcranial direct ...
- Biohybrid robotic hand may help unravel complex sensation of touchon May 15, 2024 at 8:58 am
Brain-machine interfaces are devices that enable direct communication between a brain's electrical activity and an external device such as a computer or a robotic limb that allows people to control ...
- Brain Cancer Awareness Month: Challenges and Innovations in Treatmenton May 14, 2024 at 10:31 am
In an interview with Targeted Oncology for Brain Cancer Awareness Month, Theodore Schwartz, MD, discussed the challenges of targeting brain tumors, emerging therapies, and strategies to overcome the ...
- Sofwave Introduces Pure Impact: Revolutionary Product Set to Transform Aesthetic Treatments in the US Marketon May 12, 2024 at 2:00 am
Sofwave's Pure Impact Introduces the 4th Generation of Technology and Innovation in Aesthetic Enhancement.United ...
- FDA Approves Noninvasive Bone Growth Stimulatoron May 8, 2024 at 11:32 am
The FDA has approved (by way of the more rigorous and time-consuming premarket application (PMA) path) a noninvasive bone growth stimulator. According to the summary of safety and effectiveness, the ...
via Bing News